Search

Search Constraints

You searched for: Author/Creator Kaneda, H

Search Results

2. 533TiPCANOPY-2: A phase III, placebo-controlled study of canakinumab with or without docetaxel in patients (pts) with NSCLC previously treated with PD-(L)1 inhibitors and platinum-based chemotherapy (Ctx). (24th November 2019)